SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-035098
Filing Date
2022-10-25
Accepted
2022-10-25 16:17:42
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20220930.htm   iXBRL 10-Q 2506293
2 EX-31.1 imra-ex311_6.htm EX-31.1 20742
3 EX-31.2 imra-ex312_8.htm EX-31.2 20973
4 EX-32.1 imra-ex321_10.htm EX-32.1 9855
5 EX-32.2 imra-ex322_9.htm EX-32.2 10047
  Complete submission text file 0001564590-22-035098.txt   7229524

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA imra-20220930.xsd EX-101.SCH 48657
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20220930_cal.xml EX-101.CAL 34936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20220930_def.xml EX-101.DEF 141115
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220930_lab.xml EX-101.LAB 364444
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220930_pre.xml EX-101.PRE 274902
62 EXTRACTED XBRL INSTANCE DOCUMENT imra-10q_20220930_htm.xml XML 1082816
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 221329687
SIC: 2834 Pharmaceutical Preparations